AQR Capital Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.17M | Buy |
231,574
+117,508
| +103% | +$1.61M | ﹤0.01% | 1519 |
|
|
2025
Q1 | $1.26M | Buy |
114,066
+88,577
| +348% | +$980K | ﹤0.01% | 1877 |
|
|
2024
Q4 | $271K | Sell |
25,489
-92,450
| -78% | -$985K | ﹤0.01% | 2537 |
|
|
2024
Q3 | $1.5M | Buy |
117,939
+87,649
| +289% | +$1.11M | ﹤0.01% | 1637 |
|
|
2024
Q2 | $508K | Sell |
30,290
-11,972
| -28% | -$201K | ﹤0.01% | 2049 |
|
|
2024
Q1 | $634K | Buy |
42,262
+23,879
| +130% | +$358K | ﹤0.01% | 1865 |
|
|
2023
Q4 | $276K | Buy |
+18,383
| New | +$276K | ﹤0.01% | 2092 |
|